New publications
Preparations
Cerepro
Last reviewed: 01.06.2018
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.

Indications Cerepro
Pharmacodynamics
Cerepro is a centrally acting cholinomimetic, it contains about 40.5% of metabolically protected choline. Due to this, this substance exerts its effect precisely in the brain. When the drug enters the patient's body, it begins to interact with enzymes, after which it breaks down into glycerophosphate and pure choline. Choline takes part in the biological synthesis of acetylcholine, and glycerophosphate normalizes phospholipid structures that are located in the neuronal membrane.
Thanks to this product, phosphatidylcholine and acetylcholine are synthesized in the body, which help improve blood flow and enhance metabolic processes in the central nervous system, linear blood flow increases on the side of the brain that was affected. Patients experience improved behavioral response, and spatial-temporal characteristics are normalized. The product effectively improves the main functions of the brain.
Pharmacokinetics
After the patient has taken the drug, its absorption is about 88%. It penetrates the blood-brain barrier quite easily. In the brain, the concentration of the active component is 45%. The lungs remove about 85% of the substance, the rest is excreted through feces and urine.
Use Cerepro during pregnancy
It is not used to treat pregnant women, as its effect on fetal development has not been studied. Also, the drug cannot be used during breastfeeding, because its active component penetrates into milk.
Dosing and administration
In the acute period of stroke, the dosage is as follows: 1 g of the drug (only the solution, which is administered intravenously or intramuscularly) once every 24 hours for 10 days to 2 weeks. Then the patient must be transferred to taking capsules (1.2 g): two capsules in the morning and one capsule in the daytime. This course lasts about six months.
If the condition is chronic, it is necessary to take one capsule of the medicine three times in 24 hours. The therapy lasts from 3 months to six months.
Capsules are best taken before meals.
[ 23 ]
Storage conditions
It is recommended to store the drug in a dry place protected from direct sunlight. It is important that small children do not have access to the drug. The air temperature should not exceed +25 degrees.
[ 34 ]
Shelf life
Can be stored for up to two years. Do not use the drug after the expiration date.
